Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors.
暂无分享,去创建一个
F. Christiansen | S. Mallal | Annalise M. Martin | D. Nolan | C. Pace | M. D. den Boer | E. Hammond | Louise Taylor | O. Martinez | Hannah Moore
[1] S. Mallal,et al. Assessment of precision and concordance of quantitative mitochondrial DNA assays: a collaborative international quality assurance study. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[2] D. Turnbull,et al. Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. , 2002, American journal of human genetics.
[3] T. Cihlar,et al. Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors , 2002, Antimicrobial Agents and Chemotherapy.
[4] K. Anderson,et al. Toxicity of Antiviral Nucleoside Analogs and the Human Mitochondrial DNA Polymerase* , 2001, The Journal of Biological Chemistry.
[5] B. Day,et al. Mitochondrial DNA Depletion, Oxidative Stress, and Mutation: Mechanisms 0f Dysfunction from Nucleoside Reverse Transcriptase Inhibitors , 2001, Laboratory Investigation.
[6] Alex J White,et al. Mitochondrial toxicity and HIV therapy , 2001, Sexually transmitted infections.
[7] C. Witt,et al. Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail. , 2000, Tissue antigens.
[8] C. Moore,et al. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection , 2000, AIDS.
[9] T. Kakuda,et al. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. , 2000, Clinical therapeutics.
[10] D. Turnbull,et al. Mitochondrial DNA analysis: polymorphisms and pathogenicity , 1999, Journal of medical genetics.
[11] J. Smeitink,et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway , 1998, AIDS.
[12] P. Kissinger,et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. , 1998, The New England journal of medicine.
[13] W. Copeland,et al. Characterization of the native and recombinant catalytic subunit of human DNA polymerase gamma: identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity. , 1998, Biochemistry.
[14] G. Satten,et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.
[15] J. Weiner,et al. Zidovudine and dideoxynucleosides deplete wild-type mitochondrial DNA levels and increase deleted mitochondrial DNA levels in cultured Kearns-Sayre syndrome fibroblasts. , 1996, Biochimica et biophysica acta.
[16] M. Dalakas,et al. Mitochondrial toxicity of antiviral drugs , 1995, Nature Medicine.
[17] J. L. Martin,et al. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis , 1994, Antimicrobial Agents and Chemotherapy.